Finance

Lists
Q3 2026 earnings • released • EPS beat +8,76% • Revenue beat +0,94%
See results
6446:TPE
PharmaEssentia Corp
1 380,00 TWD
+1,10%
(+15,00) 1D
13-ноя., 13:30:31 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6446...
Open
1 375,00 TWD
High
1 405,00 TWD
Low
1 370,00 TWD
Mkt. cap
582,96 млд
Avg. vol.
2,65 млн
Volume
3,70 млн
Dividend
0,10%
Quarterly dividend
0,34 TWD
Ex-dividend date
2026-ж., 9-июл.
P/E ratio
77,09
52-wk high
1 645,00 TWD
52-wk low
407,92 TWD
EPS
17,90 TWD
No. of employees
131
Open
1 375,00 TWD
High
1 405,00 TWD
Low
1 370,00 TWD
Mkt. cap
582,96 млд
Avg. vol.
2,65 млн
Volume
3,70 млн
Dividend
0,10%
Quarterly dividend
0,34 TWD
Ex-dividend date
2026-ж., 9-июл.
P/E ratio
77,09
52-wk high
1 645,00 TWD
52-wk low
407,92 TWD
EPS
17,90 TWD
No. of employees
131
News stories
From web sources and news partners
About PharmaEssentia Corp
CEO-
Employees131
Founded1990-ж., 9-май
Headquarters-
SectorHealth Care
Industry-
Last report
2026-ж., 11-ноя.
Fiscal period
Q3 2026
7,08 TWD / 6,51 TWD
+8,76%beat
Revenue / Est. (TWD)
7,76 млд / 7,69 млд
+0,94%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
4,88 млд
5,12 млд
6,86 млд
7,76 млд
Cost of goods sold
543,68 млн
621,28 млн
395,45 млн
245,13 млн
Cost of revenue
543,68 млн
621,28 млн
395,45 млн
245,13 млн
Research and development expenses
1,01 млд
857,29 млн
1,07 млд
1,22 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,77 млд
1,56 млд
2,24 млд
3,16 млд
Operating expense
2,78 млд
2,41 млд
3,31 млд
4,39 млд
Total operating expenses
3,32 млд
3,03 млд
3,70 млд
4,63 млд
Operating income
1,56 млд
2,09 млд
3,15 млд
3,13 млд
Other non operating income
4,37 млн
1,32 млн
8,58 млн
-7,94 млн
EBT including unusual items
2,01 млд
2,34 млд
3,20 млд
3,25 млд
EBT excluding unusual items
2,01 млд
2,34 млд
3,20 млд
3,25 млд
Income tax expense
536,45 млн
185,95 млн
668,64 млн
329,44 млн
Effective tax rate
26,65%
7,96%
20,90%
10,13%
Other operating expenses
-
-
-
-
Net income
1,48 млд
2,15 млд
2,53 млд
2,92 млд
Net profit margin
30,24%
41,97%
36,90%
37,67%
Earnings per share
3,58
5,21
6,13
7,08
Interest and investment income
142,46 млн
139,53 млн
148,04 млн
142,64 млн
Interest expense
-5,76 млн
-4,71 млн
-5,95 млн
-8,23 млн
Net interest expenses
136,70 млн
134,82 млн
142,08 млн
134,41 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,60 млд
2,14 млд
3,21 млд
3,41 млд
Gain or loss from assets sale
1,50 млн
-
-
82,00 миң
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору